Preventing Pressure Injuries in Neonates Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: An

Alexandra Luton1, Jae Hernandez, Clive Robert Patterson

  • 1Newborn Center, Texas Children's Hospital, Houston (Ms Luton); CMHH Quality & Safety, Children's Memorial Hermann Hospital, Houston, Texas (Ms Hernandez); Neurodiagnostic Technology School, Medical Education and Training Campus, Fort Sam Houston, Texas (Mr Patterson); MoonPenny Consulting, Delaware, Ohio (Ms Nielsen-Farrell); Neurophysiology Department, Texas Children's Hospital, Houston (Ms Thompson); and Departments of Pediatrics (Section of Neonatology) and Obstetrics and Gynecology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX (Dr Kaiser).

Insights

Implementing targeted interventions significantly reduced hospital-acquired pressure injuries (HAPIs) in neonates undergoing therapeutic hypothermia (TH) for hypoxic-ischemic encephalopathy (HIE). This collaborative approach optimized care for this vulnerable population, achieving a zero HAPI rate.

Area of Science:

  • Neonatal intensive care unit (NICU) care
  • Medical device-related pressure injuries
  • Skin integrity in vulnerable neonates

Background:

  • Hospital-acquired pressure injuries (HAPIs) are multifactorial, with medical device-related (MDR) HAPIs being a primary concern in neonates.
  • Neonates undergoing therapeutic hypothermia (TH) for hypoxic-ischemic encephalopathy (HIE) are at increased risk due to unique vulnerabilities.
  • Existing evidence-based standards may not adequately address the specific skin protection needs of this population.

Purpose of the Study:

  • To develop and implement population-specific strategies to reduce HAPIs in neonates with HIE undergoing TH.
  • To enhance existing evidence-based standards of care for this high-risk NICU population.
  • To optimize product selection, assessment practices, and documentation for HAPI prevention.

Main Methods:

  • An interprofessional team revised current protocols and care standards.
  • Plan-do-study-act (PDSA) cycles were utilized to test and refine interventions.
  • Focus on optimizing product selection, standardizing assessments, and improving documentation.

Main Results:

  • A sustained zero rate of HAPIs was achieved in the HIE population undergoing TH.
  • Near-miss data collection and analysis are ongoing for continuous process refinement.
  • Successfully adapted and implemented targeted solutions for HAPI prevention.

Conclusions:

  • Recognizing and addressing the unique skin protection needs of special NICU populations, like those on TH, is critical.
  • Collaborative, population-specific solutions are essential when standard care is insufficient.
  • Further research is needed to understand TH's influence on skin integrity and develop specific protective measures.
Abstract